Healthy Infants clinical trials

Explore recruiting healthy infants clinical trials.

Recruiting healthy infants studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Infants trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine when Administered to Healthy Infants

Poland, Spain, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety and immunogenicity of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers

Italy, Poland, Finland, Netherlands, Greece, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A parallel-group, prevention, Phase III, modified double-blind, 2-arm, study to investigate the immunogenicity and describe the safety of a quadrivalent meningococcal conjugate vaccine (MenACYW conjugate vaccine) compared with Nimenrix® when administered in a 1+1 schedule in healthy infants and toddlers at 6 and 12 months of age

Finland, Poland, Germany, Romania, Denmark, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

EarLy extra Measles immunisation during a measles Outbreak (ELMO)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

Romania, Finland, France, Italy, Denmark, Poland +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group study to investigate the safety and immunogenicity of catch-up vaccination regimens of a 21-valent pneumococcal conjugate vaccine in healthy infants, toddlers, children, and adolescents

Estonia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Healthy Infants trials by city

Healthy Infants in Toronto Healthy Infants in Vancouver Healthy Infants in Montreal Healthy Infants in Calgary Healthy Infants in Edmonton Healthy Infants in Ottawa Healthy Infants in Winnipeg Healthy Infants in Quebec City Healthy Infants in Hamilton Healthy Infants in Kitchener Healthy Infants in London Healthy Infants in Halifax Healthy Infants in New York Healthy Infants in Los Angeles Healthy Infants in Chicago Healthy Infants in Houston

Healthy Infants clinical trials

Recruiting healthy infants studies right now

HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants

Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.

Strengthening Healthy Emotional Co-regulation of Mothers With PCOS and Obesity and Their Infants

The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Immune Function and Inflammatory Conditions - a Randomized Placebo-controlled Double-blinded Intervention Trial

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants

Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation

Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama

To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Maternal High Fibre Fermented Diet Effect on Breastfed Infant Gut Microbiome

Also recruiting in Europe

A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine when Administered to Healthy Infants

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety and immunogenicity of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers

EarLy extra Measles immunisation during a measles Outbreak (ELMO)

A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group study to investigate the safety and immunogenicity of catch-up vaccination regimens of a 21-valent pneumococcal conjugate vaccine in healthy infants, toddlers, children, and adolescents

Healthy Infants trials by city

Other conditions